Neuroprotection: Understanding the Modus Operandum of Glutamate Excitotoxicity
- Comments & Ratings
This review describes research using the Promega BDNF Emax® ImmunoAssay System in a continuous medium-withdrawal method for measuring BDNF release from NMDA-treated neurons. This method was initially developed by Ann M. Marini and colleagues in 1998 in a landmark paper for ELISA-based neurotrophin detection.
Cell Notes 19, 6–7.
Publication Date: 2007